Autopsy report · NCT00637494
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Cause of deathOther
“DRC recommended stopping study as it had missed its primary endpoint”
Life of this trial
- Ran for about 6 years 3 months before it stopped.
- 292 participants enrolled.
- Results were posted on the registry 2 years 8 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Corcept Therapeutics
- Sponsor type
- Industry
- Conditions
- Psychotic Depression; Severe Major Depression With Psychotic Features; Psychosis
- Interventions
- mifepristone; placebo
- Participants
- 292
- Sites
- 42
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.